CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- DEL AM Other DEL AM
- S-3 Offering Registration Statement
- 4 Shares withheld for taxes Chief Financial Officer gave up 352 shares (to pay taxes)
- 4 Other acquisition Director acquired 952 shares (code L)
- 4 Other acquisition Director acquired 952 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 952 shares (code L)
- 4/A Other acquisition Director acquired 2,011 shares (code L)
- 4 Other acquisition Director acquired 2,852 shares (code L)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Other acquisition Director acquired 1,148 shares (code L)
- 4 Other acquisition Director acquired 1,148 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 1,148 shares (code L)
- 4 Other acquisition Director acquired 2,814 shares (code L)
- 4 Other acquisition Director acquired 3,027 shares (code L)
- 8-K Event Other events
- 4 Other acquisition Director acquired 1,093 shares (code L)
- 4 Other acquisition Director acquired 1,093 shares (code L)
Page 10 of 52 · 1,039 filings